The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global NSAIDs Drug Market Research Report 2025
Synopsis
The global NSAIDs Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for NSAIDs Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NSAIDs Drug.
Report Scope
The NSAIDs Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NSAIDs Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NSAIDs Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Segment by Type
Ibuprofen
Naproxen
Segment by Application
Hospitals
Clinics
Drugstores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NSAIDs Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global NSAIDs Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for NSAIDs Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NSAIDs Drug.
Report Scope
The NSAIDs Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NSAIDs Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NSAIDs Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Segment by Type
Ibuprofen
Naproxen
Segment by Application
Hospitals
Clinics
Drugstores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NSAIDs Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NSAIDs Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Ibuprofen
1.2.3 Naproxen
1.3 Market by Application
1.3.1 Global NSAIDs Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NSAIDs Drug Market Perspective (2019-2030)
2.2 NSAIDs Drug Growth Trends by Region
2.2.1 Global NSAIDs Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 NSAIDs Drug Historic Market Size by Region (2019-2024)
2.2.3 NSAIDs Drug Forecasted Market Size by Region (2025-2030)
2.3 NSAIDs Drug Market Dynamics
2.3.1 NSAIDs Drug Industry Trends
2.3.2 NSAIDs Drug Market Drivers
2.3.3 NSAIDs Drug Market Challenges
2.3.4 NSAIDs Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NSAIDs Drug Players by Revenue
3.1.1 Global Top NSAIDs Drug Players by Revenue (2019-2024)
3.1.2 Global NSAIDs Drug Revenue Market Share by Players (2019-2024)
3.2 Global NSAIDs Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NSAIDs Drug Revenue
3.4 Global NSAIDs Drug Market Concentration Ratio
3.4.1 Global NSAIDs Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NSAIDs Drug Revenue in 2023
3.5 NSAIDs Drug Key Players Head office and Area Served
3.6 Key Players NSAIDs Drug Product Solution and Service
3.7 Date of Enter into NSAIDs Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NSAIDs Drug Breakdown Data by Type
4.1 Global NSAIDs Drug Historic Market Size by Type (2019-2024)
4.2 Global NSAIDs Drug Forecasted Market Size by Type (2025-2030)
5 NSAIDs Drug Breakdown Data by Application
5.1 Global NSAIDs Drug Historic Market Size by Application (2019-2024)
5.2 Global NSAIDs Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America NSAIDs Drug Market Size (2019-2030)
6.2 North America NSAIDs Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America NSAIDs Drug Market Size by Country (2019-2024)
6.4 North America NSAIDs Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NSAIDs Drug Market Size (2019-2030)
7.2 Europe NSAIDs Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe NSAIDs Drug Market Size by Country (2019-2024)
7.4 Europe NSAIDs Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NSAIDs Drug Market Size (2019-2030)
8.2 Asia-Pacific NSAIDs Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific NSAIDs Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific NSAIDs Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NSAIDs Drug Market Size (2019-2030)
9.2 Latin America NSAIDs Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America NSAIDs Drug Market Size by Country (2019-2024)
9.4 Latin America NSAIDs Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NSAIDs Drug Market Size (2019-2030)
10.2 Middle East & Africa NSAIDs Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa NSAIDs Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa NSAIDs Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer NSAIDs Drug Introduction
11.1.4 Pfizer Revenue in NSAIDs Drug Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK NSAIDs Drug Introduction
11.2.4 GSK Revenue in NSAIDs Drug Business (2019-2024)
11.2.5 GSK Recent Development
11.3 Grunenthal
11.3.1 Grunenthal Company Detail
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal NSAIDs Drug Introduction
11.3.4 Grunenthal Revenue in NSAIDs Drug Business (2019-2024)
11.3.5 Grunenthal Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer NSAIDs Drug Introduction
11.4.4 Bayer Revenue in NSAIDs Drug Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi NSAIDs Drug Introduction
11.5.4 Sanofi Revenue in NSAIDs Drug Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly NSAIDs Drug Introduction
11.6.4 Eli Lilly Revenue in NSAIDs Drug Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca NSAIDs Drug Introduction
11.7.4 AstraZeneca Revenue in NSAIDs Drug Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Endo
11.8.1 Endo Company Detail
11.8.2 Endo Business Overview
11.8.3 Endo NSAIDs Drug Introduction
11.8.4 Endo Revenue in NSAIDs Drug Business (2019-2024)
11.8.5 Endo Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck NSAIDs Drug Introduction
11.9.4 Merck Revenue in NSAIDs Drug Business (2019-2024)
11.9.5 Merck Recent Development
11.10 Depomed
11.10.1 Depomed Company Detail
11.10.2 Depomed Business Overview
11.10.3 Depomed NSAIDs Drug Introduction
11.10.4 Depomed Revenue in NSAIDs Drug Business (2019-2024)
11.10.5 Depomed Recent Development
11.11 Yunnan Baiyao
11.11.1 Yunnan Baiyao Company Detail
11.11.2 Yunnan Baiyao Business Overview
11.11.3 Yunnan Baiyao NSAIDs Drug Introduction
11.11.4 Yunnan Baiyao Revenue in NSAIDs Drug Business (2019-2024)
11.11.5 Yunnan Baiyao Recent Development
11.12 Teva
11.12.1 Teva Company Detail
11.12.2 Teva Business Overview
11.12.3 Teva NSAIDs Drug Introduction
11.12.4 Teva Revenue in NSAIDs Drug Business (2019-2024)
11.12.5 Teva Recent Development
11.13 J&J
11.13.1 J&J Company Detail
11.13.2 J&J Business Overview
11.13.3 J&J NSAIDs Drug Introduction
11.13.4 J&J Revenue in NSAIDs Drug Business (2019-2024)
11.13.5 J&J Recent Development
11.14 Allergan
11.14.1 Allergan Company Detail
11.14.2 Allergan Business Overview
11.14.3 Allergan NSAIDs Drug Introduction
11.14.4 Allergan Revenue in NSAIDs Drug Business (2019-2024)
11.14.5 Allergan Recent Development
11.15 Purdue
11.15.1 Purdue Company Detail
11.15.2 Purdue Business Overview
11.15.3 Purdue NSAIDs Drug Introduction
11.15.4 Purdue Revenue in NSAIDs Drug Business (2019-2024)
11.15.5 Purdue Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
